Kenya Neurology Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4817

  • Format: PPT, PDF

Kenya Neurological Disorders Drug Market: Segmented by Disease types (Parkinson’s Diseases, Alzheimer’s Disease, Epilepsy, Multiple Sclerosis, Dementia, Migraine, Cerebrovascular Disease-Ischemic and Haemorrhagic Stroke), Drug Class (Dopaminergic Agonists, Enzyme Inhibitors, Anti-Cholinergic, Anti-Epileptic Drugs, Anti-Psychotic, Anti-Hypertensives, Sedatives Other Drug Classes), Distribution Channels (Hospital pharmacies, Retail Pharmacies, Online and Others) – Growth, Trends, and Forecasts (2019 – 2028)

Clear
SKU: 4817 Categories: ,

Report Overview

The Neurological disorders Drug market size in Kenya stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Neurological disorders are a group of disorders affecting the structure and function of the Central Nervous System (Brain and Spinal Cord) of the body mainly in adults. According to the research study conducted in Kenya’s leading public health tertiary institutions, Kenyatta National Hospital and Moi Teaching and Referral Hospital in 2018, Overall, ischaemic stroke accounted for 55.6% of the stroke cases, with women being the most affected (57.5%).  The most common risk factors were hypertension, smoking, and diabetes. One in four Kenyans aged 18–69 years have elevated blood pressure. The prevalence of hypertension is higher among women and urban residents than among men and rural residents. Alzheimer’s and Parkinson’s Disease account for the leading causes of mortality due to neurodegenerative diseases. Limited knowledge of prevalence of Parkinson’s disease in Kenya has resulted in it being neglected and its symptoms often confused with ageing.

Market Drivers

The market is majorly driven by the rising burden of Non-Communicable Diseases (NCDs) in Kenya. High prevalence of uncontrolled hypertension among Kenyan population and subsequent complications like stroke is creating growth opportunities in the Neurological Drug market. In Kenya, a quarter of the population aged 18–69 years is estimated to be hypertensive and a half pre-hypertensive.

Surge in lifestyle-associated neurological disorders among young population is expected to fuel growth in the market. Increase in prevalence of smokers, substance abuse, depression among young population and other risk factors will propel growth in the forecasted period.

Development of new and more efficient drugs by leading pharmaceutical companies will drive growth in the neurological Drug market during the forecast period.

However, there is a serious dearth of neurologists in the country that restricts growth of the market. There are only 20 neurologists practicing in Kenya and most of them are concentrated in three major cities of Nairobi, Mombasa and Kisumu. There are no neurologists in rural Kenya.

1. Kenya Neurological Disorders Drug Market Overview………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………
A. Rising Prevalence of Neurological Disorders
B. Increase in the Risk Factors Associated with Neurological Disorders
C. Development of New Drugs and Therapies in the Market
3. Major Neurological Disorders………………………………………………………………….
A. Parkinson’s Disease
B. Alzheimer’s Disease
C. Multiple Sclerosis
D. Cerebrovascular disease- Ischemic and Haemorrhagic Stroke
E. Dementia
F. Migraine
G. Psychotic Disorders
H. Others
4. Neurological Disorders Drug Market Segmentation…………………………..
A. Drug Class
I. Anti-Cholinergic
II. Dopaminergic Agonists
III. Enzyme Inhibitors
IV. Anti-Epileptic
V. Anti-Hypertensives
VI. Anti-Psychotics
VII. Sedatives
B. Distribution Channels
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online
IV. Others
5. Neurological Disorders Major Products Market Share………………………..
A. Key Findings
B. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape……………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Eli Lilly Company overview, Product & Services, Strategies & Financials
B. Johnson & Johnson Company overview, Product & Services, Strategies & Financials
C. Novartis Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Neurological drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Disease Type:

On the basis of disease type, the neurological Drug market in Kenya is segmented into Parkinson’s disease, Alzheimer’s disease, Multiple Sclerosis, Dementia, Migraine, Cerebrovascular diseases, Epilepsy and Psychotic disorders.

Cerebrovascular disease segment including Ischemic stroke and haemorrhagic stroke will grow at the fastest rate in the forecast period due to the high burden of hypertensive population in the country.

By Drug Class:

On the basis of drug class, the neurological Drug market can be segmented into anti- cholinergic, dopaminergic agonist, enzyme inhibitors, anti-epileptics, anti-hypertensives, sedatives, anti-psychotics and other drug classes.

Anti-Hypertensive drug segment will witness the fastest growth and hold the largest share in the market.

By Distribution Channels:

On the basis of distribution channels, the market can be segmented into hospital pharmacies, retail pharmacies, online and others.

Retail pharmacies account for the highest market share based on revenues generated.

 Major Players

Large pharmaceutical companies are investing heavily in the development of new drugs and therapies to treat neurological disorders. Some of the major players in the market are Eli Lilly, Novartis AG, Johnson & Johnson services, Pfizer, Inc. and Merck & Co.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements